Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Untangling the CRISPR cancer scare
First CRISPR editing trial results assuage safety concerns
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Is Crispr the Next Antibiotic? - The New York Times
The kill-switch for CRISPR that could make gene-editing safer
CRISPR, the disruptor : Nature News & Comment
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
CRISPR algorithm predicts how well gene editing will work - Scope
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR-engineered T cells in patients with refractory cancer | Science
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR, the disruptor : Nature News & Comment
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
